Gilead (NASDAQ:GILD) reported third quarter earnings that missed analysts' expectations on Thursday and revenue that was inline with forecasts.
The firm reported earnings per share of $1.75 on revenue of $5.60B. Analysts polled by anticipated EPS of $1.76 on revenue of $5.6B. That compared to EPS of $1.84 on revenue of $5.6B in the same period a year earlier. The company had reported EPS of $1.82 on revenue of $5.69B in the previous quarter.
Gilead follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Novartis ADR earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. analysts expected EPS of $1.33 on revenue of $11.71B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
